Related Experiment Videos
Hand-assisted laparoscopic splenectomy for splenic tumors
Hiroshi Yano1, Yoshiaki Nakano, Takeshi Tono
1Department of Surgery, NTT West Osaka Hospital, Osaka, Japan. yano-h@mhc.west.ntt.co.jp
Digestive Surgery
|July 9, 2004
Summary
Hand-assisted laparoscopic splenectomy (HALS) is a feasible surgical option for splenic tumors. This study shows HALS offers favorable outcomes for both benign and malignant splenic neoplasms, with no major complications.
Area of Science:
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- The efficacy of hand-assisted laparoscopic splenectomy (HALS) for splenic tumors is not well-established.
- Clinical outcomes following HALS for splenic neoplasms require further investigation.
Purpose of the Study:
- To evaluate the feasibility and clinical outcomes of hand-assisted laparoscopic splenectomy (HALS) for patients with splenic tumors.
- To assess the safety and effectiveness of HALS in treating both benign and malignant splenic neoplasms.
Main Methods:
- Retrospective analysis of 10 patients who underwent HALS for splenic tumors.
- Evaluation of intraoperative, postoperative, and recovery parameters.
Main Results:
- HALS was successfully performed in all 10 patients (5 benign, 5 malignant tumors) without conversion to open surgery.
- No intra- or postoperative complications were observed. All patients survived with a mean follow-up of 26 months.
- Postoperative recovery metrics (e.g., time to flatus, ambulation, hospital stay) were comparable to standard laparoscopic splenectomy.
Conclusions:
- Hand-assisted laparoscopic splenectomy (HALS) is a viable and safe surgical approach for splenic tumors, including malignant neoplasms.
- HALS demonstrates promising results for spleen tumor treatment, supporting its use for both benign and malignant conditions.